Table of Contents

company-logo

Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. It also conducts a Phase 2a clinical trial, the BALANCED study, to evaluate EFX in the treatment of biopsy-confirmed NASH patients. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

Akero Therapeutics Dividend Announcement

• Akero Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Akero Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Akero Therapeutics Dividend History

Akero Therapeutics Dividend Yield

Akero Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Akero Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Akero Therapeutics Financial Ratios

P/E ratio-9.67
PEG ratio21.96
P/B ratio3.11
ROE-32.52%
Payout ratio-142.00%
Current ratio17.25
Quick ratio17.25
Cash Ratio7.30

Akero Therapeutics Dividend FAQ

Does Akero Therapeutics stock pay dividends?
Akero Therapeutics does not currently pay dividends to its shareholders.
Has Akero Therapeutics ever paid a dividend?
No, Akero Therapeutics has no a history of paying dividends to its shareholders. Akero Therapeutics is not known for its dividend payments.
Why doesn't Akero Therapeutics pay dividends?
There are several potential reasons why Akero Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Akero Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Akero Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Akero Therapeutics a dividend aristocrat?
Akero Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Akero Therapeutics a dividend king?
Akero Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Akero Therapeutics a dividend stock?
No, Akero Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Akero Therapeutics stocks?
To buy Akero Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Akero Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.